Finland· FI-REL-REL60730
Ikervis
A ciclosporin product containing ciclosporin, registered in Finland by Santen Oy. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ciclosporin is registered in 14 of 19 countries.
Countries holding a registration under ATC S01XA18 (ciclosporin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Ciclosporin · ATC S01XA18
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Ciclosporin
- Manufacturer
- Santen Oy
- Country
- Finland (FI)
- ATC code
- S01XA18
- ATC class
- Ciclosporin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciclosporin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIKERVISSanten OY, Tampere
- SwedenIKERVIS 1 mg/ml Ögondroppar, emulsionSanten Oy
- BelgiumIkervis 1 mg/mlSanten
- PolandIkervisSanten Oy
- IcelandIkervisSanten Oy
- SwitzerlandIkervis, 1 mg/ml collyre en émulsion (unidoses)Santen SA
- FranceIKERVIS 1 mg/mL, collyre en émulsionSANTEN OY
- NetherlandsIKERVIS 1 mg/ml oogdruppels, emulsieSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Cequa®, Neoimmun
- Belgium · Neoral-Sandimmun, Sandimmun
- Bulgaria · Сандимун Неорал
- Cyprus · Sandimmun Neoral
- Czechia · Ciclosporin Viatris, Equoral
- Germany · Cequa, Cicloral
- Denmark · Ciqorin, Menelri
- Estonia · Equoral, Sandimmun Neoral
- Spain · Cequa, Ciqorin
- France · Cequa, Ciclograft
- United Kingdom (Northern Ireland) · Capimune, Capsorin
- Greece · Imunofar, Sandimmun
- Croatia · Ciklosporin Alkaloid, Equoral
- Hungary · Sandimmun, Sandimmun Neoral
- Ireland · Deximune, Neoral
- Iceland · Ciqorin, Ikervis
- Italy · Cequa, Ciqorin
- Liechtenstein · Ikervis, Verkazia
- Lithuania · Equoral, Sandimmun Neoral
- Luxembourg · Neoral-Sandimmun, Sandimmun
- Latvia · Sandimmun Neoral
- Malta · Deximune, Sandimmun Neoral
- Netherlands · Cequa, Ciclosporin Teva
- Norway · Cequa, Ikervis
- Poland · Cyclaid, Equoral
- Portugal · Ciclosporina Flica Germed Farmacêutica, Ciclosporina Generis
- Romania · Cequa, Sandimmun Neoral
- Sweden · Cequa, Ciklosporin Ivax
- Slovenia · Sandimmun, Sandimmun Neoral
- Slovakia · Ciclosporin Viatris, Equoral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1a014a3-6aec-464f-9045-e2c19ec3a525 GET /v1/drugs/c1a014a3-6aec-464f-9045-e2c19ec3a525?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, emulsio",
"route": "Silmän pinnalle",
"ddd_unit": null,
"strength": "1 mg/ml",
"atc_label": "siklosporiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/15/990/003-005",
"fimea_rel_id": "REL60730",
"authorised_at": "2021-12-16"
}See everything about ciclosporin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.